Amantadine

Kathryn Dzintars, Pharm.D., BCPS, Paul G. Auwaerter, M.D.

INDICATIONS

FDA

  • Influenza A (prophylaxis and treatment: no longer routinely recommended due to high incidence of resistant influenza strains, unless circulating strain known to be susceptible)
  • Parkinson disease

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 9, 2022